1. Houssami N, Hunter K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer. 2017;3:12.
2. Michalopoulos D, Dibden A, Duffy SW. National collation of breast screening interval cancer data 2006–2008. published 2015.
3. • Guidance on Interval cancers, Reporting, classification and monitoring of interval cancers and cancers following previous assessment 2017 PHE publications, gateway number: 2017216. This documents helps define how interval cancers are classified to ensure that there is standardisation within the UK. This is important regarding education but also auditing practise going forward.
4. • Guidance on applying Duty of Candour and disclosing audit results, 2016. PHE publications gateway number: 2016343. This is an important document outlining the processes regarding Duty of Candour and Disclosure of audit. It emphasises the importance of being honest and objective when dealing with interval cancers.
5. Tornberg S, Kemetli L, Ascunce N, Hofvind S, Anttila A, Sèradour B, et al. A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev. 2010;19:87–93.